Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6385)
All Articles published online
|
Nov 28, 2010 (publication date) through Feb 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li W, Qin J, Sun YH, Liu TS. Neoadjuvant chemotherapy for advanced gastric cancer: A meta-analysis. World J Gastroenterol 2010; 16(44): 5621-5628 [PMID: 21105197 DOI: 10.3748/wjg.v16.i44.5621] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i44/5621.htm |
| Number | Citing Articles |
| 1 |
Manabu Yamamoto, Yoshihisa Sakaguchi, Ayumi Matsuyama, Keiji Yoshinaga, Shinichi Tsutsui, Teruyoshi Ishida. Surgery after Preoperative Chemotherapy for Patients with Unresectable Advanced Gastric Cancer. Oncology 2013; 85(4): 241 doi: 10.1159/000354420
|
| 2 |
A-Man Xu, Lei Huang, Wei Liu, Shuang Gao, Wen-Xiu Han, Zhi-Jian Wei, Tone Frost Bathen. Neoadjuvant Chemotherapy Followed by Surgery versus Surgery Alone for Gastric Carcinoma: Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS ONE 2014; 9(1): e86941 doi: 10.1371/journal.pone.0086941
|
| 3 |
Ning-ning Bian, Yong-hong Wang, Guang-tao Min. S-1 combined with paclitaxel may benefit advanced gastric cancer: Evidence from a systematic review and meta-analysis. International Journal of Surgery 2019; 62: 34 doi: 10.1016/j.ijsu.2018.11.010
|
| 4 |
Sameer H. Patel, David A. Kooby. Gastric Adenocarcinoma Surgery and Adjuvant Therapy. Surgical Clinics of North America 2011; 91(5): 1039 doi: 10.1016/j.suc.2011.06.009
|
| 5 |
Kai Zhou, Anqiang Wang, Jingtao Wei, Ke Ji, Zhongwu Li, Xin Ji, Tao Fu, Ziyu Jia, Xiaojiang Wu, Ji Zhang, Zhaode Bu. The Value of Perioperative Chemotherapy for Patients With Hepatoid Adenocarcinoma of the Stomach Undergoing Radical Gastrectomy. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.789104
|
| 6 |
Masahiro Hirakawa, Yasushi Sato, Hiroyuki Ohnuma, Tetsuji Takayama, Tamotsu Sagawa, Takayuki Nobuoka, Keisuke Harada, Hiroshi Miyamoto, Yasuhiro Sato, Yasuo Takahashi, Shinich Katsuki, Michiaki Hirayama, Minoru Takahashi, Michihiro Ono, Masahiro Maeda, Kohichi Takada, Tsuyoshi Hayashi, Tsutomu Sato, Koji Miyanishi, Rishu Takimoto, Masayoshi Kobune, Koichi Hirata, Junji Kato. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker. Cancer Chemotherapy and Pharmacology 2013; 71(3): 789 doi: 10.1007/s00280-013-2073-5
|
| 7 |
Kequn Xu, Yang Yang, Qin Huang, Hua Jiang, Valia Boosalis. Gastric Cardiac Cancer. 2018; : 263 doi: 10.1007/978-3-319-79114-2_14
|
| 8 |
Marc Ychou, Valérie Boige, Jean-Pierre Pignon, Thierry Conroy, Olivier Bouché, Gilles Lebreton, Muriel Ducourtieux, Laurent Bedenne, Jean-Michel Fabre, Bernard Saint-Aubert, Jean Genève, Philippe Lasser, Philippe Rougier. Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial. Journal of Clinical Oncology 2011; 29(13): 1715 doi: 10.1200/JCO.2010.33.0597
|
| 9 |
E. Samalin. Traitement préopératoire des adénocarcinomes oesogastriques. Oncologie 2013; 15(3-4): 149 doi: 10.1007/s10269-013-2267-9
|
| 10 |
Xiang Wang, Lin Zhao, Hongfeng Liu, Dingrong Zhong, Wei Liu, Guangliang Shan, Fen Dong, Weisheng Gao, Chunmei Bai, Xiaoyi Li. A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer. British Journal of Cancer 2016; 114(12): 1326 doi: 10.1038/bjc.2016.126
|
| 11 |
John M. Creasy, Debra A. Goldman, Mithat Gonen, Vikas Dudeja, Gokce Askan, Olca Basturk, Vinod P. Balachandran, Peter J. Allen, Ronald P. DeMatteo, Michael I. D’Angelica, William R. Jarnagin, T. Peter Kingham. Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment Strategies. Journal of Gastrointestinal Surgery 2017; 21(8): 1254 doi: 10.1007/s11605-017-3436-8
|
| 12 |
Alberto Bianchi, Francisco Espin. ¿Dónde estamos en el tratamiento del cáncer gástrico? Experiencias y evidencias después de 30 años. Medicina Clínica 2013; 140(7): 307 doi: 10.1016/j.medcli.2012.10.016
|
| 13 |
Federico Coccolini, Matteo Nardi, Giulia Montori, Marco Ceresoli, Andrea Celotti, Stefano Cascinu, Paola Fugazzola, Matteo Tomasoni, Olivier Glehen, Fausto Catena, Yutaka Yonemura, Luca Ansaloni. Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials. International Journal of Surgery 2018; 51: 120 doi: 10.1016/j.ijsu.2018.01.008
|
| 14 |
K. Parry, L. Haverkamp, R.C.G. Bruijnen, P.D. Siersema, G.J.A. Offerhaus, J.P. Ruurda, R. van Hillegersberg. Staging of adenocarcinoma of the gastroesophageal junction. European Journal of Surgical Oncology (EJSO) 2016; 42(3): 400 doi: 10.1016/j.ejso.2015.11.014
|
| 15 |
A. Mirza, S. Pritchard, I. Welch. The Postoperative Component of MAGIC Chemotherapy Is Associated with Improved Prognosis following Surgical Resection in Gastric and Gastrooesophageal Junction Adenocarcinomas. International Journal of Surgical Oncology 2013; 2013: 1 doi: 10.1155/2013/781742
|
| 16 |
Vincenzo Catalano, Francesco Graziano. Management of Advanced Gastric Cancer. 2011; : 28 doi: 10.2217/ebo.11.165
|
| 17 |
Chang-Ming Huang, Mu Xu, Jia-Bin Wang, Chao-Hui Zheng, Ping Li, Jian-Wei Xie, Jian-Xian Lin, Jun Lu. Is tumor size a predictor of preoperative N staging in T2–T4a stage advanced gastric cancer?. Surgical Oncology 2014; 23(1): 5 doi: 10.1016/j.suronc.2014.01.003
|
| 18 |
Chenglou Zhu, Mingxu Da, Yaoqi Li, Lingzhi Peng. Case report: pathological complete response after S-1/oxaliplatin regimen combined with trastuzumab and tislelizumab in patients with locally advanced gastric cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1425572
|
| 19 |
B. Xiong, L. Ma, Y. Cheng, C. Zhang. RETRACTED: Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: An updated meta-analysis of randomized controlled trials. European Journal of Surgical Oncology (EJSO) 2014; 40(10): 1321 doi: 10.1016/j.ejso.2014.01.006
|
| 20 |
Jian He, Hua Shi, Zhuping Zhou, Jun Chen, Wenxian Guan, Hao Wang, Haiping Yu, Song Liu, Zhengyang Zhou, Xiaofeng Yang, Tian Liu. Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1726-7
|
| 21 |
Huai-Qing Luo, Li Han, Yan Jiang. Meta-analysis of Six Randomized Control Trials of Chemotherapy Plus Anti-HER Monoclonal Antibody for Advanced Gastric and Gastroesophageal Cancer. Asian Pacific Journal of Cancer Prevention 2014; 15(13): 5343 doi: 10.7314/APJCP.2014.15.13.5343
|
| 22 |
Karen Becker, Daniel Reim, Alexander Novotny, Christian Meyer zum Büschenfelde, Jutta Engel, Helmut Friess, Heinz Höfler, Rupert Langer. Proposal for a Multifactorial Prognostic Score That Accurately Classifies 3 Groups of Gastric Carcinoma Patients With Different Outcomes After Neoadjuvant Chemotherapy and Surgery. Annals of Surgery 2012; 256(6): 1002 doi: 10.1097/SLA.0b013e318262a591
|
| 23 |
Guang‐Tan Lin, Zhi‐Yu Liu, Zhi‐Xin Shang‐Guan, Gui‐Rong Zeng, Jian‐Xian Lin, Ju Wu, Qi‐Yue Chen, Jian‐Wei Xie, Ping Li, Chang‐Ming Huang, Chao‐Hui Zheng. Comparison of the efficacy between immunochemotherapy and chemotherapy in gastric cancer accompanied with synchronous liver metastases: A real‐world retrospective study. Cancer Medicine 2023; 12(11): 12221 doi: 10.1002/cam4.5917
|
| 24 |
Wilson L Costa, Felipe JF Coimbra, Ricardo C Fogaroli, Héber SC Ribeiro, Alessandro L Diniz, Maria Dirlei FL Begnami, Celso AL Mello, Marcelo F Fanelli, Milton JB Silva, José Humberto Fregnani, André L Montagnini. Adjuvant chemoradiotherapy after d2-lymphadenectomy for gastric cancer: the role of n-ratio in patient selection. results of a single cancer center. Radiation Oncology 2012; 7(1) doi: 10.1186/1748-717X-7-169
|
| 25 |
Bing-Hong Xiong, Yong Cheng, Li Ma, Cai-Quan Zhang. An Updated Meta-Analysis of Randomized Controlled Trial Assessing the Effect of Neoadjuvant Chemotherapy in Advanced Gastric Cancer. Cancer Investigation 2014; 32(6): 272 doi: 10.3109/07357907.2014.911877
|
| 26 |
Chun-Dong Zhang, Yong-Ji Zeng, Hong-Wu Li, Zhe-Ming Zhao, Jia-Kui Zhang, Dong-Qiu Dai. Neoadjuvant Chemotherapy for Nonmetastatic Esophago-Gastric Adenocarcinomas: A Systematic Review and Meta-Analysis. Cancer Investigation 2013; 31(6): 421 doi: 10.3109/07357907.2013.802801
|
| 27 |
Lei Jiang, Ke-hu Yang, Quan-lin Guan, Yan Chen, Peng Zhao, Jin-hui Tian. Survival Benefit of Neoadjuvant Chemotherapy for Resectable Cancer of the Gastric and Gastroesophageal Junction. Journal of Clinical Gastroenterology 2015; 49(5): 387 doi: 10.1097/MCG.0000000000000212
|
| 28 |
Johan L. Dikken, Jurriën Stiekema, Cornelis J. H. van de Velde, Marcel Verheij, Annemieke Cats, Michel W. J. M. Wouters, Johanna W. van Sandick. Quality of Care Indicators for the Surgical Treatment of Gastric Cancer: A Systematic Review. Annals of Surgical Oncology 2013; 20(2): 381 doi: 10.1245/s10434-012-2574-1
|
| 29 |
Erling A Bringeland, Hans H Wasmuth, Jon E Grønbech. Perioperative chemotherapy for resectable gastric cancer – what is the evidence?. Scandinavian Journal of Gastroenterology 2017; 52(6-7): 647 doi: 10.1080/00365521.2017.1293727
|
| 30 |
Seow Chee Herng, Norah Htet Htet, Cho Naing, Sandro Pasquali. A comparison of neoadjuvant therapies for gastroesophageal and gastric cancer on tumour resection rate: A network meta-analysis. PLOS ONE 2022; 17(9): e0275186 doi: 10.1371/journal.pone.0275186
|
| 31 |
Frédéric Fiteni, Sophie Paget‐Bailly, Mathieu Messager, Thierry N'Guyen, Zaher Lakkis, Pierre Mathieu, Najib Lamfichekh, Alain Picard, Bilell Benzidane, Denis Cléau, Franck Bonnetain, Christophe Borg, Christophe Mariette, Stefano Kim. Docetaxel, Cisplatin, and 5‐Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma. Cancer Medicine 2016; 5(11): 3085 doi: 10.1002/cam4.885
|
| 32 |
Yoshiyuki Fujiwara, Shuji Takiguchi, Kiyokazu Nakajima, Hiroshi Miyata, Makoto Yamasaki, Yukinori Kurokawa, Kaoru Okada, Masaki Mori, Yuichiro Doki. Neoadjuvant Intraperitoneal and Systemic Chemotherapy for Gastric Cancer Patients with Peritoneal Dissemination. Annals of Surgical Oncology 2011; 18(13): 3726 doi: 10.1245/s10434-011-1770-8
|
| 33 |
Binghong Xiong, Li Ma, Wei Huang, Yong Cheng, Qikang Zhao, Jingshan Liu. WITHDRAWN: Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: An updated meta-analysis of 12 randomized controlled trials. Surgical Oncology 2014; doi: 10.1016/j.suronc.2014.11.005
|
| 34 |
Birendra Kumar Sah, Benyan Zhang, Huan Zhang, Jian Li, Fei Yuan, Tao Ma, Min Shi, Wei Xu, Zhenglun Zhu, Wentao Liu, Chao Yan, Chen Li, Bingya Liu, Min Yan, Zhenggang Zhu. Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer. Nature Communications 2020; 11(1) doi: 10.1038/s41467-020-19965-6
|
| 35 |
Gan Liu, Shougen Cao, Xiaodong Liu, Zequn Li, Yulong Tian, Xingqi Zhang, Hao Zhong, Yanbing Zhou. Effect of perioperative probiotic supplements on postoperative short-term outcomes in gastric cancer patients receiving neoadjuvant chemotherapy: A double-blind, randomized controlled trial. Nutrition 2022; 96: 111574 doi: 10.1016/j.nut.2021.111574
|
| 36 |
John M. Creasy, Debra A. Goldman, Vikas Dudeja, Maeve A. Lowery, Andrea Cercek, Vinod P. Balachandran, Peter J. Allen, Ronald P. DeMatteo, Peter T. Kingham, Michael I. D'Angelica, William R. Jarnagin. Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes. Journal of the American College of Surgeons 2017; 224(5): 906 doi: 10.1016/j.jamcollsurg.2016.12.058
|
| 37 |
Leila Sisic, Susanne Blank, Henrik Nienhüser, Georg Martin Haag, Dirk Jäger, Tom Bruckner, Katja Ott, Thomas Schmidt, Alexis Ulrich. The postoperative part of perioperative chemotherapy fails to provide a survival benefit in completely resected esophagogastric adenocarcinoma. Surgical Oncology 2020; 33: 177 doi: 10.1016/j.suronc.2017.06.001
|
| 38 |
Ai-Wen Wu, Peng Yuan, Zi-Yu Li, Lei Tang, Zhao-De Bu, Hui Ren, Jia-Fu Ji. Capecitabine Plus Paclitaxel Induction Treatment in Gastric Cancer Patients with Liver Metastasis: A Prospective, Uncontrolled, Open-Label Phase II Clinical Study. Future Oncology 2016; 12(18): 2107 doi: 10.2217/fon-2016-0145
|
| 39 |
Hyo Song Kim, Woong Sub Koom, Song-Ee Baek, Hyoung-Il Kim, Minkyu Jung, Seung-Hoon Beom, Beodeul Kang, Hyunki Kim, Jee Suk Chang, Yoon Young Choi, Taeil Son, Jae-Ho Cheong, Sung Hoon Noh, Eun Hye Kim, Jun Chul Park, Sung Kwan Shin, Sang Kil Lee, Yong Chan Lee, Su-Jin Shin, Hyunsoo Chung, Inkyung Jung, Hyun Cheol Chung, Joon Seok Lim, Woo Jin Hyung, Sun Young Rha. Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer. Radiotherapy and Oncology 2019; 140: 143 doi: 10.1016/j.radonc.2019.06.029
|
| 40 |
E.C. Gertsen, C. de Jongh, H.J.F. Brenkman, A.C. Mertens, I.A.M.J. Broeders, M. Los, D. Boerma, D. ten Bokkel Huinink, L. van Leeuwen, F.J. Wessels, R. van Hillegersberg, J.P. Ruurda. The additive value of restaging-CT during neoadjuvant chemotherapy for gastric cancer. European Journal of Surgical Oncology 2020; 46(7): 1247 doi: 10.1016/j.ejso.2020.04.002
|
| 41 |
BAOJI SONG, HONGJIE ZHAN, QUAN BIAN, JUNPING GU. Piperlongumine inhibits gastric cancer cells via suppression of the JAK1,2/STAT3 signaling pathway. Molecular Medicine Reports 2016; 13(5): 4475 doi: 10.3892/mmr.2016.5091
|
| 42 |
M. Stahl, H. Wilke. Therapie-Handbuch Grundwerk inkl 6. Lfg.. 2015; : 1 doi: 10.1016/B978-3-437-22107-1.50150-3
|
| 43 |
Fuhai Ma, Bingzhi Wang, Liyan Xue, Wenzhe Kang, Yang Li, Weikun Li, Hao Liu, Shuai Ma, Yantao Tian. Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach. Journal of Cancer Research and Clinical Oncology 2020; 146(8): 2135 doi: 10.1007/s00432-020-03214-w
|
| 44 |
Shahriyar Hashemzadeh, Ali Pourzand, Mohammad Hossein Somi, Sina Zarrintan, Reza Javad-Rashid, Ali Esfahani. The effects of neoadjuvant chemotherapy on resectability of locally-advanced gastric adenocarcinoma: A clinical trial. International Journal of Surgery 2014; 12(10): 1061 doi: 10.1016/j.ijsu.2014.08.349
|
| 45 |
Haejin In, Ethan Ravetch, Marisa Langdon-Embry, Bryan Palis, Jaffer A. Ajani, Wayne L. Hofstetter, David P. Kelsen, Takeshi Sano. The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging. Gastric Cancer 2018; 21(1): 1 doi: 10.1007/s10120-017-0765-y
|
| 46 |
Se Hoon Park, Soon Il Lee. Recent Advances in Chemotherapy of Gastric Cancer. Korean Journal of Medicine 2012; 82(4): 417 doi: 10.3904/kjm.2012.82.4.417
|
| 47 |
Xiaolong Qi, Yanna Liu, Wei Wang, Danxian Cai, Wende Li, Jialiang Hui, Chuan Liu, Yanxia Zhao, Guoxin Li. Management of advanced gastric cancer: An overview of major findings from meta-analysis. Oncotarget 2016; 7(47): 78180 doi: 10.18632/oncotarget.12102
|
| 48 |
Zhi-Feng Miao, Xing-Yu Liu, Zhen-Ning Wang, Ting-Ting Zhao, Ying-Ying Xu, Yong-Xi Song, Jin-Yu Huang, Hao Xu, Hui-Mian Xu. Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4027-0
|
| 49 |
Nuriye Ozdemir, Huseyin Abali, Murat Vural, Suayib Yalcin, Berna Oksuzoglu, Burak Civelek, Dilek Oguz, Birol Bostanci, Bulent Yalcin, Nurullah Zengin. Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study. Cancer Chemotherapy and Pharmacology 2014; 74(6): 1139 doi: 10.1007/s00280-014-2586-6
|
| 50 |
I. D. Amelina, A. M. Karachun, D. V. Nesterov, L. N. Shevkunov, A. S. Artemieva, S. S. Bagnenko, S. L. Trofimov. ROLE OF COMPUTED TOMOGRAPHY WITH PNEUMOGASTROGRAPHY IN DETERMINING THE REGRESSION GRADE OF LOCALLY ADVANCED GASTRIC CANCER AFTER NEOADJUVANT CHEMOTHERAPY. Siberian journal of oncology 2021; 20(5): 18 doi: 10.21294/1814-4861-2021-20-5-18-30
|
| 51 |
Xuguang Chen, Jennifer R. Eads, John B. Ammori, Aryavarta M. Kumar, Tithi Biswas, Jennifer A. Dorth. Adjuvant and Neoadjuvant Options in Resectable Gastric Cancer: Is There an Optimal Treatment Approach?. Current Oncology Reports 2015; 17(4) doi: 10.1007/s11912-015-0442-4
|
| 52 |
Е. О. Mantsyrev, A. V. Privalov, S. V. Kuvaev, К. V. Semikopov, I. A. Gavrishkin. Evaluation of the efficiency of perioperative chemotherapy in the complex treatment of gastric cancer. Ural Medical Journal 2021; 20(2): 17 doi: 10.52420/2071-5943-2021-20-2-17-22
|
| 53 |
Jun-hua Zhao, Peng Gao, Yong-xi Song, Jing-xu Sun, Xiao-wan Chen, Bin Ma, Yu-chong Yang, Zhen-ning Wang. Which is better for gastric cancer patients, perioperative or adjuvant chemotherapy: a meta-analysis. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2667-5
|
| 54 |
Xuejun Gan, Shen Li, Yiding Wang, Hong Du, Ying Hu, Xiaofang Xing, Xiaojing Cheng, Yan Yan, Ziyu Li. Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer. International Journal of Molecular Sciences 2023; 24(6): 5482 doi: 10.3390/ijms24065482
|
| 55 |
Jan Bornschein, Theodore Rokkas, Michael Selgrad, Peter Malfertheiner. Gastric Cancer: Clinical Aspects, Epidemiology and Molecular Background. Helicobacter 2011; 16(s1): 45 doi: 10.1111/j.1523-5378.2011.00880.x
|
| 56 |
Ya’nan Yang, Xue Yin, Lei Sheng, Shan Xu, Lingling Dong, Lian Liu. Perioperative chemotherapy more of a benefit for overall survival than adjuvant chemotherapy for operable gastric cancer: an updated Meta-analysis. Scientific Reports 2015; 5(1) doi: 10.1038/srep12850
|
| 57 |
Yung-Sung Yeh, Yi-Ting Chen, Hsiang-Lin Tsai, Ching-Wen Huang, Cheng-Jen Ma, Wei-Chih Su, Chun-Ming Huang, Ming-Yii Huang, Huang-Ming Hu, Chien-Yu Lu, Jaw-Yuan Wang. Predictive Value of ERCC1, ERCC2, and XRCC Expression for Patients with Locally Advanced or Metastatic Gastric Cancer Treated with Neoadjuvant mFOLFOX-4 Chemotherapy. Pathology & Oncology Research 2020; 26(2): 1105 doi: 10.1007/s12253-019-00666-5
|
| 58 |
Emmanuelle Samalin, Marc Ychou. Neoadjuvant therapy for gastroesophageal adenocarcinoma. World Journal of Clinical Oncology 2016; 7(3): 284-292 doi: 10.5306/wjco.v7.i3.284
|
| 59 |
Yi Liao, Zu‐li Yang, Jun‐sheng Peng, Jun Xiang, Jian‐ping Wang. Neoadjuvant chemotherapy for gastric cancer: A meta‐analysis of randomized, controlled trials. Journal of Gastroenterology and Hepatology 2013; 28(5): 777 doi: 10.1111/jgh.12152
|
| 60 |
Shuai Dong, Ji-Ren Yu, Qin Zhang, Xiao-Sun Liu. Neoadjuvant chemotherapy in controlling lymph node metastasis for locally advanced gastric cancer in a Chinese population. Journal of Chemotherapy 2016; 28(1): 59 doi: 10.1179/1973947815Y.0000000028
|
| 61 |
Louis de Mestier, Sophie Lardière-Deguelte, Julien Volet, Reza Kianmanesh, Olivier Bouché. Recent insights in the therapeutic management of patients with gastric cancer. Digestive and Liver Disease 2016; 48(9): 984 doi: 10.1016/j.dld.2016.04.010
|
| 62 |
Deng-Hai Mi, Zheng Li, Ke-Hu Yang, Nong Cao, Anne Lethaby, Jin-Hui Tian, Nancy Santesso, Bin Ma, Yao-Long Chen, Ya-Li Liu. Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: A systematic review and meta-analysis of randomised controlled trials. International Journal of Hyperthermia 2013; 29(2): 156 doi: 10.3109/02656736.2013.768359
|
| 63 |
Caroline M. Woolston, Srinivasan Madhusudan, Irshad N. Soomro, Dileep N. Lobo, Alexander M. Reece-Smith, Simon L. Parsons, Stewart G. Martin. Thioredoxin interacting protein and its association with clinical outcome in gastro-oesophageal adenocarcinoma. Redox Biology 2013; 1(1): 285 doi: 10.1016/j.redox.2013.04.006
|
| 64 |
Shunli Liu, Hua Shi, Changfeng Ji, Wenxian Guan, Ling Chen, Yingshi Sun, Lei Tang, Yue Guan, Weifeng Li, Yun Ge, Jian He, Song Liu, Zhengyang Zhou. CT textural analysis of gastric cancer: correlations with immunohistochemical biomarkers. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-30352-6
|
| 65 |
Yasuo Sakamoto, Yoshihisa Sakaguchi, Masahiko Sugiyama, Kazuhito Minami, Yasushi Toh, Takeshi Okamura. Surgical Indications for Gastrectomy Combined with Distal or Partial Pancreatectomy in Patients with Gastric Cancer. World Journal of Surgery 2012; 36(10): 2412 doi: 10.1007/s00268-012-1681-2
|
| 66 |
Junya Shirai, Chikara Kunisaki, Ten-i Godai, Kazuteru Watanabe, Takashi Oshima, Norio Yukawa, Shouichi Fujii, Yasushi Rino, Munetaka Masuda. A Case of Locally Advanced Colon Cancer Treated with Resection After CapeOX and Bevacizumab Combination Chemotherapy. Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) 2012; 37(4): 813 doi: 10.4030/jjcs.37.813
|
| 67 |
Jian-Xian Lin, Yan-Chang Xu, Wei Lin, Fang-Qin Xue, Jian-Xin Ye, Wei-Dong Zang, Li-Sheng Cai, Jun You, Jian-Hua Xu, Jian-Chun Cai, Yi-Hui Tang, Jian-Wei Xie, Ping Li, Chao-Hui Zheng, Chang-Ming Huang. Effectiveness and Safety of Apatinib Plus Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer. JAMA Network Open 2021; 4(7): e2116240 doi: 10.1001/jamanetworkopen.2021.16240
|
| 68 |
Ju Seok Kim, Sun Hyung Kang, Hee Seok Moon, Jae Kyu Sung, Hyun Yong Jeong, Ji Young Sul. Clinical Outcome of Doublet and Triplet Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer. The Korean Journal of Gastroenterology 2016; 68(5): 245 doi: 10.4166/kjg.2016.68.5.245
|
| 69 |
Li-Bo Sun, Guo-Jie Zhao, Da-Yong Ding, Bin Song, Rui-Zhi Hou, Yong-Chao Li. Comparison between better and poorly differentiated locally advanced gastric cancer in preoperative chemotherapy: a retrospective, comparative study at a single tertiary care institute. World Journal of Surgical Oncology 2014; 12(1): 280 doi: 10.1186/1477-7819-12-280
|
| 70 |
Zongqiong Sun, Xiaofang Cheng, Yuxi Ge, Lin Shao, Yinghua Xuan, Gen Yan. An application study of low-dose computed tomography perfusion imaging for evaluation of the efficacy of neoadjuvant chemotherapy for advanced gastric adenocarcinoma. Gastric Cancer 2018; 21(3): 413 doi: 10.1007/s10120-017-0763-0
|
| 71 |
Catharina Ruf, Oliver Thomusch, Matthias Goos, Frank Makowiec, Gerald Illerhaus, Guenther Ruf. Impact of neoadjuvant chemotherapy with PELF-protocoll versus surgery alone in the treatment of advanced gastric carcinoma. BMC Surgery 2014; 14(1) doi: 10.1186/1471-2482-14-5
|
| 72 |
Jian-Hong Yu, Zao-Zao Wang, Ying-Chong Fan, Mao-Xing Liu, Kai Xu, Nan Zhang, Zhen-Dan Yao, Hong Yang, Cheng-Hai Zhang, Jia-Di Xing, Ming Cui, Xiang-Qian Su. Comparison of neoadjuvant chemotherapy followed by surgery vs. surgery alone for locally advanced gastric cancer: a meta-analysis. Chinese Medical Journal 2021; 134(14): 1669 doi: 10.1097/CM9.0000000000001603
|
| 73 |
S. D. Nelen, R. H. A. Verhoeven, V. E. P. P. Lemmens, J. H. W. de Wilt, K. Bosscha. Increasing survival gap between young and elderly gastric cancer patients. Gastric Cancer 2017; 20(6): 919 doi: 10.1007/s10120-017-0708-7
|
| 74 |
Thales Paulo BATISTA, Candice Amorim de Araujo Lima SANTOS, Gustavo Fernandes Godoy ALMEIDA. PERIOPERATIVE CHEMOTHERAPY IN LOCALLY ADVANCED GASTRIC CANCER. Arquivos de Gastroenterologia 2013; 50(3): 236 doi: 10.1590/S0004-28032013000200042
|